Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T69085 | Target Info | |||
Target Name | Transcription factor AP-1 (JUN) | ||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Proto-oncogene c-jun; P39; C-jun proto-oncogene; Activator protein-1; Activator protein 1; AP1; AP-1 transcription factor | ||||
Target Type | Discontinued Target | ||||
Gene Name | JUN | ||||
Biochemical Class | Basic leucine zipper bZIP | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 3 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [2] | |||
3 | Co-crystal Structure | [3] | |||
4 | Co-fractionation | [3] | |||
5 | Co-localization | [4] | |||
6 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Cyclic AMP-dependent transcription factor ATF-2 (ATF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRE.BP1; CREB.2; CREB2; HB16; TREB7 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Co-localization | [8] | |||
4 | Fluorescence Resonance Energy Transfer | [9] | |||
5 | Reconstituted Complex | [10] | |||
Interacting Target Name | E3 ubiquitin-protein ligase COP1 (RFWD2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF200; RING-type E3 ubiquitin transferase RFWD2; RING finger protein 200; RING finger and WD repeat domain protein 2; hCOP1; E3 ubiquitinprotein ligase RFWD2; COP1; Constitutive photomorphogenesis protein 1 homolog | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Affinity Capture-Western | [12] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIR2-like protein 1; SIR2L1; Regulatory protein SIR2 homolog 1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; hSIR2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [13] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Biochemical Activity | [15] | |||
4 | Reconstituted Complex | [15] | |||
Cell division cycle proteins | [+] 1 Cell division cycle proteins | + | |||
Interacting Protein Name | Retinoblastoma-associated protein (RB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OSRC; PPP1R130; RB; p105.Rb; pRb; pp110 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Reconstituted Complex | [17] | |||
3 | Yeast two hybrid | [16] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [10] | |||
2 | Yeast two hybrid | [18] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | Rotamase Pin1 (PIN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prolyl isomerase Pin1; PPIase Pin1; Peptidyl-prolyl cis-trans isomerase Pin1; Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; Peptidyl prolyl cis/trans isomerase Pin1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Reconstituted Complex | [20] | |||
Kinases | [+] 6 Kinases | + | |||
Interacting Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1c; SAPK1c; SAPK1; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Biochemical Activity | [22] | |||
3 | Reconstituted Complex | [23] | |||
4 | Yeast two hybrid | [24] | |||
Interacting Target Name | Stress-activated protein kinase JNK2 (JNK2) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1a; SAPK1a; PRKM9; Mitogen-activated protein kinase 9; Mitogen-activated protein kinase 8-interacting protein 2; MAPK 9; MAP kinase 9; Jun-N-terminal kinase 2; JNK-interacting protein 2; JNK-55; JNK MAP kinase scaffold protein 2; JIP-2; Islet-brain-2; IB-2; C-jun-amino-terminal kinase interacting protein 2; C-Jun N-terminal kinase 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [25] | |||
2 | Reconstituted Complex | [26] | |||
3 | Yeast two hybrid | [24] | |||
Interacting Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase GSK3B; GSK-3 beta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [27] | |||
2 | Co-localization | [28] | |||
Interacting Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [20] | |||
2 | Reconstituted Complex | [29] | |||
Interacting Target Name | MAPK/ERK kinase kinase 1 (MAP3K1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mitogen-activated protein kinase kinase kinase 1; Mitogenactivated protein kinase kinase kinase 1; MEKK1; MEKK 1; MEKK; MEK kinase 1; MAPKKK1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Biochemical Activity | [31] | |||
Interacting Target Name | Stress-activated protein kinase JNK3 (JNK3) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1b; SAPK1b; PRKM10; Mitogen-activated protein kinase 10; MAPK 10; MAP kinase p49 3F12; MAP kinase 10; JNK3A; C-Jun N-terminal kinase 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [32] | |||
2 | Reconstituted Complex | [26] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [33] | |||
2 | Reconstituted Complex | [34] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Co-localization | [35] | |||
3 | Reconstituted Complex | [36] | |||
4 | Yeast two hybrid | [35] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Protein Name | Amyloid-like protein 2 (APLP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APLP.2; APPH; APPL2; CDEBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [10] | |||
2 | Yeast two hybrid | [18] | |||
Transcription regulators | [+] 14 Transcription regulators | + | |||
Interacting Target Name | Proto-oncogene c-Fos (c-Fos) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Proto-oncogene c-Fos; G0S7; G0/G1 switch regulatory protein 7; C-fos; Cellular oncogene fos | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [37] | |||
2 | Affinity Capture-Western | [38] | |||
3 | Co-crystal Structure | [39] | |||
4 | Co-fractionation | [40] | |||
5 | Co-localization | [41] | |||
6 | Fluorescence Resonance Energy Transfer | [9] | |||
7 | Protein-Fragment Complementation Assay | [42] | |||
8 | Reconstituted Complex | [43] | |||
9 | Yeast two hybrid | [44] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Co-localization | [46] | |||
3 | Far Western | [47] | |||
4 | Reconstituted Complex | [5] | |||
Interacting Target Name | Activating transcription factor 4 (ATF-4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TXREB; Tax-responsive enhancer element-binding protein 67; Taxresponsive enhancer elementbinding protein 67; TaxREB67; DNA-binding protein TAXREB67; DNAbinding protein TAXREB67; Cyclic AMP-responsive element-binding protein 2; Cyclic AMPresponsive elementbinding protein 2; Cyclic AMP-dependent transcription factor ATF-4; Cyclic AMPdependent transcription factor ATF4; CREB-2; CREB2; cAMP-responsive element-binding protein 2; cAMPresponsive elementbinding protein 2; cAMP-dependent transcription factor ATF-4; cAMPdependent transcription factor ATF4 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Co-localization | [28] | |||
2 | Fluorescence Resonance Energy Transfer | [9] | |||
3 | Reconstituted Complex | [48] | |||
4 | Yeast two hybrid | [18] | |||
Interacting Target Name | Cyclic-AMP-dependent transcription factor ATF-3 (ATF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-dependent transcription factor ATF-3; cAMP-dependent transcription factor ATF-3; Activating transcription factor 3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [49] | |||
3 | Fluorescence Resonance Energy Transfer | [9] | |||
4 | Reconstituted Complex | [48] | |||
Interacting Target Name | Fos-related antigen 1 (FOSL1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Fra-1; FRA1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [38] | |||
2 | Fluorescence Resonance Energy Transfer | [9] | |||
3 | Reconstituted Complex | [43] | |||
4 | Yeast two hybrid | [43] | |||
Interacting Target Name | Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit; Polyomavirus enhancer-binding protein 2 alpha Asubunit; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEBP2-alpha A; PEBP2A; PEA2-alpha A; Osteoblast-specific transcription factor 2; OSF-2; OSF2; Oncogene AML-3; Core-binding factor subunit alpha-1; CBF-alpha-1; CBFA1; AML3; Acute myeloid leukemia 3 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Reconstituted Complex | [50] | |||
3 | Yeast two hybrid | [51] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Reconstituted Complex | [52] | |||
3 | Yeast two hybrid | [52] | |||
Interacting Target Name | Nuclear factor erythroid 2-related factor 2 (Nrf2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor, erythroid derived 2, like 2; NRF2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [53] | |||
2 | Reconstituted Complex | [53] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [54] | |||
2 | Reconstituted Complex | [55] | |||
Interacting Target Name | Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-responsive element-binding protein 1; Cyclic AMP responseelement-binding protein; CREB-1; CREB; cAMP-responsive element-binding protein 1; CAMP-response element binding protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Affinity Capture-Western | [56] | |||
Interacting Target Name | Fos-related antigen 2 (FOSL2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FRA-2; FRA2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [37] | |||
2 | Yeast two hybrid | [43] | |||
Interacting Protein Name | Basic leucine zipper transcriptional factor ATF-like 3 (BATF3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JDP1; JUNDM1; SNFT | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Fluorescence Resonance Energy Transfer | [9] | |||
Interacting Protein Name | Protein fosB (FOSB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AP.1; G0S3; GOS3; GOSB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Protein-Fragment Complementation Assay | [57] | |||
Interacting Protein Name | Nuclear factor of activated T cells 2 (NFATC2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFAT1; NFATP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Reconstituted Complex | [58] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Polyubiquitin-C (UBC) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG20; ubiquitin C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-Fragment Complementation Assay | [59] | |||
2 | Yeast two hybrid | [18] | |||
Other proteins | [+] 3 Other proteins | + | |||
Interacting Target Name | F-box and WD-40 domain protein 7 (Fbxw7) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SEL-10; SEL10; hCdc4; hAgo; FBX30; FBW7; F-box-WD40 repeat protein 6; F-box/WD repeat-containing protein 7; F-box protein Fbxw6; F-box protein FBX30; F-box protein FBW7; F-box and WD-40 domain-containing protein 7; Archipelago homolog | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Protein-peptide | [60] | |||
2 | Reconstituted Complex | [20] | |||
3 | Yeast two hybrid | [60] | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [61] | |||
2 | Co-localization | [62] | |||
3 | Reconstituted Complex | [63] | |||
Interacting Protein Name | Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAL; FIG; GOPC1; PIST; dJ94G16.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Reconstituted Complex | [10] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Cigarette smoke extract regulates cytosolic phospholipase A2 expression via NADPH oxidase/MAPKs/AP-1 and p300 in human tracheal smooth muscle cells. J Cell Biochem. 2011 Feb;112(2):589-99. | ||||
REF 2 | Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. J Biol Chem. 2011 Nov 25;286(47):40974-86. | ||||
REF 3 | Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. Biochemistry. 2002 Nov 26;41(47):13956-64. | ||||
REF 4 | Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood. 2004 Mar 15;103(6):2135-42. | ||||
REF 5 | The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A. Oncogene. 1999 Apr 8;18(14):2311-21. | ||||
REF 6 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 7 | Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. J Leukoc Biol. 1994 Jul;56(1):27-35. | ||||
REF 8 | Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell. 2004 Nov 19;16(4):521-35. | ||||
REF 9 | Networks of bZIP protein-protein interactions diversified over a billion years of evolution. Science. 2013 May 10;340(6133):730-4. | ||||
REF 10 | A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One. 2010 Feb 24;5(2):e9289. | ||||
REF 11 | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol. 2015 Jan 21;11(1):775. | ||||
REF 12 | Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem. 2003 May 30;278(22):19682-90. | ||||
REF 13 | A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex. Mol Cell Biol. 2013 Apr;33(8):1487-502. | ||||
REF 14 | Inhibition of transcriptional activity of c-JUN by SIRT1. Biochem Biophys Res Commun. 2008 Nov 28;376(4):793-6. | ||||
REF 15 | SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem. 2010 Mar 5;285(10):7097-110. | ||||
REF 16 | Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site. J Biol Chem. 1999 Feb 26;274(9):5454-61. | ||||
REF 17 | Rb binds c-Jun and activates transcription. EMBO J. 1998 Apr 15;17(8):2342-52. | ||||
REF 18 | A human MAP kinase interactome. Nat Methods. 2010 Oct;7(10):801-5. | ||||
REF 19 | Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001 Jul 2;20(13):3459-72. | ||||
REF 20 | Multivalent Interactions with Fbw7 and Pin1 Facilitate Recognition of c-Jun by the SCFFbw7 Ubiquitin Ligase. Structure. 2018 Jan 2;26(1):28-39.e2. | ||||
REF 21 | Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol. 1997 Mar;17(3):1170-9. | ||||
REF 22 | Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J Biol Chem. 2004 Mar 5;279(10):9023-9. | ||||
REF 23 | Regulation of two JunD isoforms by Jun N-terminal kinases. J Biol Chem. 2002 Aug 16;277(33):29710-8. | ||||
REF 24 | Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation. Cancer Res. 2007 Sep 15;67(18):8725-35. | ||||
REF 25 | c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 1996 Nov 29;87(5):929-39. | ||||
REF 26 | Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996 Jun 3;15(11):2760-70. | ||||
REF 27 | PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells. Mol Biol Cell. 2007 Mar;18(3):1118-27. | ||||
REF 28 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 29 | Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J Biol Chem. 1999 Jul 30;274(31):21900-7. | ||||
REF 30 | CSN6 positively regulates c-Jun in a MEKK1-dependent manner. Cell Cycle. 2015;14(19):3079-87. | ||||
REF 31 | 1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. J Biol Chem. 2003 Aug 15;278(33):30711-8. | ||||
REF 32 | Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 1998 May 22;280(5367):1262-5. | ||||
REF 33 | Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene. J Biol Chem. 2007 Apr 20;282(16):11732-41. | ||||
REF 34 | Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J Biol Chem. 2001 Sep 28;276(39):36361-9. | ||||
REF 35 | A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 1996 Oct 3;383(6599):453-7. | ||||
REF 36 | Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature. 2000 Apr 6;404(6778):617-21. | ||||
REF 37 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 38 | Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA. J Biol Chem. 2001 Aug 24;276(34):32362-72. | ||||
REF 39 | Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature. 1995 Jan 19;373(6511):257-61. | ||||
REF 40 | c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol. 2010 Aug;30(15):3767-78. | ||||
REF 41 | Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res. 2012 Aug 15;72(16):4214-24. | ||||
REF 42 | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. Biochem J. 2011 Sep 15;438(3):495-503. | ||||
REF 43 | Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of AP1 activity. Oncogene. 1997 May 1;14(17):2091-8. | ||||
REF 44 | ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. J Biol Chem. 1999 Sep 24;274(39):27981-8. | ||||
REF 45 | CBP alleviates the intramolecular inhibition of ATF-2 function. J Biol Chem. 1998 Oct 30;273(44):29098-105. | ||||
REF 46 | Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem. 2005 Sep 23;280(38):32569-77. | ||||
REF 47 | Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 1994 Jul 21;370(6486):226-9. | ||||
REF 48 | Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3720-4. | ||||
REF 49 | ATF3 enhances c-Jun-mediated neurite sprouting. Brain Res Mol Brain Res. 2003 Dec 12;120(1):38-45. | ||||
REF 50 | AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem. 2001 Jun 8;276(23):20029-38. | ||||
REF 51 | Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem. 2002 Jan 4;277(1):816-22. | ||||
REF 52 | Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 1998 Aug 27;394(6696):909-13. | ||||
REF 53 | Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 1998 Dec 17;17(24):3145-56. | ||||
REF 54 | Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol. 2006 Mar;26(5):1770-85. | ||||
REF 55 | c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem. 1999 Oct 8;274(41):29572-81. | ||||
REF 56 | Heterodimer formation between CREB and JUN proteins. Oncogene. 1990 Mar;5(3):295-302. | ||||
REF 57 | Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis. Cell Rep. 2017 Oct 10;21(2):442-454. | ||||
REF 58 | The C-terminal region of human NFATc2 binds cJun to synergistically activate interleukin-2 transcription. Mol Immunol. 2010 Aug;47(14):2314-22. | ||||
REF 59 | Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14782-7. | ||||
REF 60 | The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science. 2004 Feb 27;303(5662):1374-8. | ||||
REF 61 | The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. Blood. 2005 May 1;105(9):3686-90. | ||||
REF 62 | Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells. 1999 Dec;4(12):743-56. | ||||
REF 63 | Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling. Mol Cell. 2006 Aug;23(4):547-59. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.